Heparin-Induced Thrombocytopenia

Suspect immune HIT when thrombocytopenia develops after unfractionated or low-molecular-weight heparin exposure, particularly with a platelet fall beginning around day 4 or 5 of exposure, new thrombosis, or both. HIT is driven by platelet-activating antibodies to PF4-heparin complexes and is a prothrombotic—not bleeding-predominant—drug reaction. ScienceDirect+1ScienceDirectHeparin-induced thrombocytopenia: An illustrated review - ScienceDirectScienceDirectHeparin-Induced Thrombocytopenia: Diagnosis and Management - ScienceDirect

Calculate the 4Ts score before ordering laboratory testing. Its four elements are the relative platelet-count fall, timing of decline, thrombosis or other sequelae, and the presence of alternative causes of thrombocytopenia. A score below 4 should generally redirect evaluation toward non-HIT causes rather than trigger routine HIT immunoassay testing; a score of 4 or greater should trigger prompt HIT-directed testing and management. Oxford Academic+3Oxford AcademicHeparin-induced thrombocytopenia: a challenging diagnosis in haemodialysis—state of art and review of the literatureWolters KluwerAccuracy of Diagnosing Heparin-Induced... : JAMA Network OpenWolters KluwerHeparin-Induced Thrombocytopenia in Patients... : Critical Care ExplorationsASHDiagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis | Blood | American Society of Hematology

Reassess alternative explanations explicitly before labeling HIT: in dialysis-associated thrombocytopenia, the differential includes infection, pseudothrombocytopenia, antiphospholipid syndrome, implicated drugs, and dialyzer membrane or sterilization effects. In cardiac surgery, PF4-heparin antibodies are frequent: approximately 50% of about 950 patients developed antibodies within 30 days by polyspecific ELISA, without an associated increase in death or thromboembolism. Testing in that setting should therefore be limited to patients with an appropriately high clinical probability. Oxford Academic+1Oxford AcademicHeparin-induced thrombocytopenia: a challenging diagnosis in haemodialysis—state of art and review of the literatureWolters KluwerDiagnosis and management of heparin‐induced... : British Journal of Haematology

For intermediate- or high-probability HIT, obtain a validated PF4/heparin antibody immunoassay, preferably an assay restricted to IgG antibodies. British guidance recommends that initial ELISAs have sensitivity greater than 95% and detect IgG only; a negative high-sensitivity ELISA can exclude HIT. Wolters KluwerWolters KluwerDiagnosis and management of heparin‐induced... : British Journal of Haematology

A positive PF4/heparin assay identifies antibodies but not necessarily pathogenic platelet activation. Many immunoassays detect non-platelet-activating IgG as well as IgM and IgA antibodies, which limits their clinical specificity and positive predictive value. Interpret a positive result jointly with the 4Ts score, platelet course, thrombotic phenotype, and—when available—a functional assay. ScienceDirect+3ScienceDirectA clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopeniaWolters KluwerAccuracy of Diagnosing Heparin-Induced... : JAMA Network OpenWolters KluwerDiagnosis and management of heparin‐induced... : British Journal of HaematologyPubMedFunctional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review - PubMed

Use ELISA optical density as a probability modifier rather than a stand-alone treatment threshold. Higher optical density values correlate with serotonin-release assay positivity and thrombosis risk. In one surgical and cardiac ICU cohort, serotonin-release assay positivity occurred in 81.8% of patients with ELISA optical density at least 2.0, compared with 4.5% at 0.85 to 1.99 and 1.0% at 0 to 0.84. jacc+1jaccHeparin-Induced Thrombocytopenia: A Comprehensive Clinical ...Wolters KluwerOvertreatment of Heparin-Induced Thrombocytopenia... : Critical Care Medicine

Avoid overinterpreting antibody positivity after cardiac surgery or other high-seropositivity settings. A polyspecific ELISA cutoff of optical density 0.4 identified frequent postoperative antibodies without increased thromboembolism or death, illustrating why indiscriminate testing creates false diagnostic signals. Wolters KluwerWolters KluwerDiagnosis and management of heparin‐induced... : British Journal of Haematology

Order a platelet-activation assay after a positive immunoassay in a patient with intermediate or high 4Ts probability. The serotonin-release assay (SRA) and heparin-induced platelet activation assay (HIPA) are established functional approaches; both test whether patient antibody-heparin-PF4 complexes activate donor platelets. jacc+4jaccHeparin-Induced Thrombocytopenia: A Comprehensive Clinical ...ScienceDirectHeparin-induced thrombocytopenia: An illustrated review - ScienceDirectWolters KluwerAccuracy of Diagnosing Heparin-Induced... : JAMA Network OpenASHDiagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis | Blood | American Society of HematologyPubMedFunctional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review - PubMed

Functional assays improve specificity because they identify platelet-activating antibodies rather than antibody binding alone. In SRA, serotonin release from platelet dense granules is measured; in HIPA, washed donor platelets are combined with patient serum and heparin and platelet aggregation is assessed. jacc+2jaccHeparin-Induced Thrombocytopenia: A Comprehensive Clinical ...Wolters KluwerHeparin-Induced Thrombocytopenia in Patients... : Critical Care ExplorationsPubMedFunctional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review - PubMed

Do not delay acute management in a patient with intermediate or high clinical probability solely because functional testing is available only through specialized laboratories. Functional assays are technically challenging, differ by platelet donor selection, sample preparation, heparin concentration, endpoint, and control interpretation, and are often not rapidly available. Wolters Kluwer+2Wolters KluwerAccuracy of Diagnosing Heparin-Induced... : JAMA Network OpenASHDiagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis | Blood | American Society of HematologyPubMedFunctional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review - PubMed

Treat discordant results as a diagnostic problem rather than a reflex mandate for indefinite HIT labeling. Immunoassay-positive but functional-assay-negative results can occur because detected antibodies are nonactivating; interpretation should return to the 4Ts score, optical density, thrombosis, assay characteristics, and medication effects. Potent P2Y12 inhibition has been reported to yield false-negative SRA results. jacc+3jaccUnmasking Essential Thrombocythemia in Heparin-Induced ... - JACCScienceDirectA clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopeniaWolters KluwerAccuracy of Diagnosing Heparin-Induced... : JAMA Network OpenWolters KluwerHeparin-Induced Thrombocytopenia in Patients... : Critical Care Explorations

For a 4Ts score of at least 4, immediately stop unfractionated heparin and low-molecular-weight heparin, send the immunoassay, and start nonheparin anticoagulation while testing proceeds. This approach addresses the prothrombotic interval before laboratory confirmation; heparin avoidance plus nonheparin anticoagulation are the core acute management measures. ScienceDirect+1ScienceDirectHeparin-induced thrombocytopenia: An illustrated review - ScienceDirectOxford AcademicHeparin-induced thrombocytopenia: a challenging diagnosis in haemodialysis—state of art and review of the literature

Argatroban is a direct thrombin inhibitor used for acute HIT, but impaired hepatic function is a major selection constraint. Its monitoring can also be difficult when aPTT is confounded by HIT-associated consumptive coagulopathy. Do not select argatroban without accounting for these limitations. jaccjaccUse of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia

Fondaparinux has been used off label in suspected acute HIT, including patients with intermediate or high clinical probability. Registry data described it as effective and safe without HIT-specific complications, but randomized trial data were identified as needed and fondaparinux does not carry an acute-HIT indication. Document its off-label status when it is selected. jaccjaccUse of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia

For hemodialysis-associated suspected HIT, stop heparin and use nonheparin anticoagulation when 4Ts is at least 4. In patients with a history of HIT, danaparoid or citrate are described options for dialysis anticoagulation, although danaparoid has limited access and is not approved in the United States. jacc+1jaccUse of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced ThrombocytopeniaOxford AcademicHeparin-induced thrombocytopenia: a challenging diagnosis in haemodialysis—state of art and review of the literature

HIT overdiagnosis is common when clinicians bypass pretest probability assessment. In an ICU study of 135 tested patients, 80 had positive PF4/heparin ELISAs, but only 11 had positive SRA results; 21.5% received argatroban or lepirudin. The discrepancy illustrates the clinical cost of treating ELISA positivity without adequate 4Ts and functional-assay integration. Wolters KluwerWolters KluwerOvertreatment of Heparin-Induced Thrombocytopenia... : Critical Care Medicine

Use an IgG-specific, high-sensitivity initial ELISA and retain the quantitative optical density in the chart and handoff. A positive result should be interpreted with the clinical estimate of pretest probability; a negative high-sensitivity assay excludes HIT, while a positive assay requires assessment for platelet activation. jacc+2jaccHeparin-Induced Thrombocytopenia: A Comprehensive Clinical ...Wolters KluwerAccuracy of Diagnosing Heparin-Induced... : JAMA Network OpenWolters KluwerDiagnosis and management of heparin‐induced... : British Journal of Haematology

When HIT remains plausible, actively assess for thrombosis rather than relying on the platelet count alone. HIT is associated with extensive venous and arterial thrombosis, limb loss, and death; mortality was 22% in a VITT cohort, but that outcome estimate applies to VITT rather than heparin-induced thrombocytopenia and should not be transferred to HIT. NEJM+1NEJMClinical Features of Vaccine-Induced Immune Thrombocytopenia ...ASHDiagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis | Blood | American Society of Hematology

Record the ultimate diagnostic status precisely: suspected HIT, immunoassay-positive/functional assay pending, functional-confirmed HIT, or HIT excluded. This prevents inappropriate long-term heparin avoidance after a low-probability or functionally unconfirmed antibody result. ScienceDirect+2ScienceDirectA clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopeniaWolters KluwerAccuracy of Diagnosing Heparin-Induced... : JAMA Network OpenWolters KluwerDiagnosis and management of heparin‐induced... : British Journal of Haematology